Search results

Found 5,000 pages
AUTHOR: Kevin Grogan

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Amgen opens biologics facility in Singapore

Amgen says it has completed construction of its first ‘next-generation’ biomanufacturing facility, located in Singapore. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/amgen_opens_biologics_facility_in_singapore_1002792

Roche signs Parkinson's pact with 23andMe

Roche’s Genentech unit has linked up with personal genetics company 23andMe to identify new therapeutic targets for Parkinson’s disease. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_signs_parkinsons_pact_with_23andme_970837

Otsuka tests drug for childhood TB

Otsuka Pharmaceutical Co says that enrollment has begun for "a ground-breaking clinical programme" looking at its investigational drug delamanid for paediatric multidrug-resistant tuberculosis (MDR-TB). - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/otsuka_tests_drug_for_childhood_tb_1005351

B-MS inks fibrosis pact with Calibr

Bristol-Myers Squibb has linked up with the California Institute for Biomedical Research to develop anti-fibrotic therapies. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/b-ms_inks_fibrosis_pact_with_calibr_970805

Sanofi and BI ink biologics manufacturing deal

Sanofi has signed up Boehringer Ingelheim as its partner to manufacture monoclonal antibodies. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/sanofi_and_bi_ink_biologics_manufacturing_deal_970872

Shire extends offer for ViroPharma again

Shire has extended its tender offer to buy ViroPharma for a second time, now expiring on midnight January 23. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/shire_extends_offer_for_viropharma_again_1001342

Teva gets FDA OK for generic Combivir

Teva Pharmaceutical Industries has been granted the first approval to market a generic version of the HIV drug Combivir. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/teva_gets_fda_ok_for_generic_combivir_980970

Nestle pact with stem cell biotech CDI

Food giant Nestle has linked up with USA-based stem cell specialist Cellular Dynamics International. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/nestle_pact_with_stem_cell_biotech_cdi_1001327

FDA approves Novartis eye drops Pazeo

Novartis unit Alcon says the US Food and Drug Administration has approved Pazeo for the treatment of ocular itching associated with allergic conjunctivitis. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/fda_approves_novartis_eye_drops_pazeo_970966

XTL buys Teva's stake in Proteologics

XTL Biopharmaceuticals has bought a major stake in fellow Israeli drugmaker Proteologics from Teva Pharmaceutical Industries. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/xtl_buys_tevas_stake_in_proteologics_976154

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download